Literature DB >> 1686654

Influence of different benzodiazepines on the experimental morphine abstinence syndrome.

R Maldonado1, J A Micó, O Valverde, M C Saavedra, I Leonsegui, J Gibert-Rahola.   

Abstract

The abuse of benzodiazepines by narcotic addicts has been well documented. However, the pharmacological basis of this abuse is not clear. In this study the effects of different benzodiazepines (flunitrazepam: 0.5, 1 and 2 mg/kg; nitrazepam: 0.5, 1, 2.5, 5 and 10 mg/kg; diazepam: 0.5, 1, 2.5, 5 and 10 mg/kg; chlordiazepoxide: 0.5, 1, 2.5, 5 and 10 mg/kg; and triazolam: 0.5, 1 and 2 mg/kg) on the morphine withdrawal syndrome in mice have been compared. Drugs were administered 30 min before naloxone-induced withdrawal. All benzodiazepines tested induced similar changes in some of the signs of morphine abstinence: decreased jumping behavior and increased wet dog shake frequency. Jumping behavior was particularly decreased by triazolam and wet dog shakes were mainly increased by flunitrazepam and nitrazepam. Forepaw treading was reduced by flunitrazepam, diazepam and triazolam, increased by nitrazepam and not changed by chlordiazepoxide. Tremor was effectively reduced by diazepam but less reliably by the other benzodiazepines. Teeth chattering was reduced by flunitrazepam and diazepam. These results indicate that benzodiazepines can interfere with the expression of the morphine withdrawal syndrome.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1686654     DOI: 10.1007/bf02244309

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  31 in total

1.  Hypersensitivity to noradrenaline in cortex after chronic morphine: relevance to tolerance and dependence.

Authors:  C Llorens; M P Martres; M Baudry; J C Schwartz
Journal:  Nature       Date:  1978-08-10       Impact factor: 49.962

2.  Diazepam in the management of heroin withdrawal in adolescents: preliminary report.

Authors:  I F Litt; A S Colli; M I Cohen
Journal:  J Pediatr       Date:  1971-04       Impact factor: 4.406

3.  Quantitative method for assessing one symptom of the withdrawal syndrome in mice after chronic morphine administration.

Authors:  I Marshall; M Weinstock
Journal:  Nature       Date:  1971-11-26       Impact factor: 49.962

4.  GABAergic mechanisms in antinociception.

Authors:  J Sawynok
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1984       Impact factor: 5.067

5.  Comparative study in mice of flunitrazepam vs. diazepam on morphine withdrawal syndrome.

Authors:  J Gibert-Rahola; R Maldonado; J A Micó; I Leonsegui; M C Saavedra
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1988       Impact factor: 5.067

6.  Effects of dapiprazole, clonidine and yohimbine on the development of dependence and withdrawal behaviour in mice.

Authors:  P Valeri; B Martinelli; G Pimpinella; C Severini
Journal:  Drug Alcohol Depend       Date:  1989-01       Impact factor: 4.492

7.  Enigmatic action of ciclosporine A on the naloxone-precipitated morphine withdrawal syndrome in mice.

Authors:  H Berthold; J F Borel; E Flückiger
Journal:  Neuroscience       Date:  1989       Impact factor: 3.590

8.  Pharmacodynamics of triazolam after intravenous administration.

Authors:  R B Smith; P D Kroboth; P D Varner
Journal:  J Clin Pharmacol       Date:  1987-12       Impact factor: 3.126

Review 9.  Relative abuse liability of triazolam: experimental assessment in animals and humans.

Authors:  R R Griffiths; R J Lamb; N A Ator; J D Roache; J V Brady
Journal:  Neurosci Biobehav Rev       Date:  1985       Impact factor: 8.989

10.  Dopaminergic mechanisms in precipitated withdrawal in morphine-dependent rats.

Authors:  M Ary; B Cox; P Lomax
Journal:  J Pharmacol Exp Ther       Date:  1977-02       Impact factor: 4.030

View more
  4 in total

Review 1.  Acute opioid dependence: characterizing the early adaptations underlying drug withdrawal.

Authors:  Andrew C Harris; Jonathan C Gewirtz
Journal:  Psychopharmacology (Berl)       Date:  2005-02-05       Impact factor: 4.530

2.  Adenosine receptor agonists attenuate and adenosine receptor antagonists exacerbate opiate withdrawal signs.

Authors:  G B Kaplan; M T Sears
Journal:  Psychopharmacology (Berl)       Date:  1996-01       Impact factor: 4.530

3.  Opioid antagonists differ according to negative intrinsic efficacy in a mouse model of acute dependence.

Authors:  Ellen A Walker; Steven N Sterious
Journal:  Br J Pharmacol       Date:  2005-08       Impact factor: 8.739

4.  Comparison of the opioid receptor antagonist properties of naltrexone and 6 beta-naltrexol in morphine-naïve and morphine-dependent mice.

Authors:  Mary F Divin; M C Holden Ko; John R Traynor
Journal:  Eur J Pharmacol       Date:  2008-01-24       Impact factor: 4.432

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.